AR010550A1 - CEPHALOSPORINE DERIVATIVES, THEIR USE, THE PROCESS TO MANUFACTURE THEM AND THE PHARMACEUTICAL PREPARATIONS CONTAINING THEM. - Google Patents
CEPHALOSPORINE DERIVATIVES, THEIR USE, THE PROCESS TO MANUFACTURE THEM AND THE PHARMACEUTICAL PREPARATIONS CONTAINING THEM.Info
- Publication number
- AR010550A1 AR010550A1 ARP970105152A ARP970105152A AR010550A1 AR 010550 A1 AR010550 A1 AR 010550A1 AR P970105152 A ARP970105152 A AR P970105152A AR P970105152 A ARP970105152 A AR P970105152A AR 010550 A1 AR010550 A1 AR 010550A1
- Authority
- AR
- Argentina
- Prior art keywords
- lower alkyl
- alkyl
- phenyl
- hydroxy
- heterocyclyl
- Prior art date
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Abstract
Derivados de cefalosporina de formula general (I) en la que R1 es halogeno, alquilo inferior, fenilo, bencilo, estirilo, naftilo o heterociclilo; estandoel alquilo inferior, fenilo, bencilo, estirilo naftilo y heterociclilo opcionalmentesus tituido por al menos uno de halogeno, hidroxi, alquiloinferior, opocionalmente sustituido, alcoxi inferior opcionalmente sustituido, fenilo opcionalmente sustituido, amino, alquil-inferior-amino, di-alquil-inferior-amino, carboxi, alquil-inferior-ca rboxi, o carbamoílo; o alquil- inferior carbamoilo; R4 y R5 son independientemente hidrogeno, alquilo inferioro fenilo; X es S, O, NH o CH2; n es 0, 1 o 2; m es 0 o 1; s es 0 o 1; R2 es hidrogeno, hidroxi, -CH2-CONHR6 alquilo-inferior- Qr, cicloalquilo-Qr, alcoxiinferior, alquenilo inferior, cicloalquenilo-Qr, alquinilo inferior, aralquilo- Qr, arilo-Qr, ariloxi, aralcoxi, un anillo heterocíclico o un heterociclilo-Qr,el alquilo inferior, cicloalquilo, alcoxi inferior,alquenilo inferi or, aralquilo, arilo, ariloxi, aralcoxi y el anillo hterocíclico pueden estarsustituidos con al menos un grupo seleccionado de carboxi, amnio, nitro, ciano, -SO2NHR6 alquilo inferior opcionalmente sustituido con fluoro,alcoxi inferior,hidrox i, halogeno, -CONR6R7, -CHCONR6R7, -N(R7)COOR8, R7CO-, R7OCO-, R7COO-, -C(R7R9)CO2R8, -C(R7R9)CONR7R10, donde R6 es hidrogeno, alquilo inferior ocicloalquilo o arilo; R7 y R9 son independientemente hidrogeno o alquiloinferior; R8 es hidrog eno, alquilo inferior, alquenilo infeior o un grupoprotector de ácido carboxílico; y R10 es hidrogeno, omega-hidroxi-alquilo, fenilo, naftilo o heterociclilo, estando el fenilo, naftilo heterociclilo nosustituido osustituidos con al menos uno de los grupos de hidrox opcionalmente protegido, halogeno, alquilo inferior o omega-hidroxialquiloCephalosporin derivatives of general formula (I) in which R1 is halogen, lower alkyl, phenyl, benzyl, styryl, naphthyl or heterocyclyl; lower alkyl, phenyl, benzyl, naphthyl styryl and heterocyclyl being optionally substituted by at least one of halogen, hydroxy, lower alkyl, optionally substituted, optionally substituted lower alkoxy, optionally substituted phenyl, amino, lower alkyl-amino, di-lower alkyl. -amino, carboxy, lower-alkyl-ca rboxi, or carbamoyl; or lower alkyl carbamoyl; R4 and R5 are independently hydrogen, lower alkyl, or phenyl; X is S, O, NH or CH2; n is 0, 1 or 2; m is 0 or 1; s is 0 or 1; R2 is hydrogen, hydroxy, -CH2-CONHR6 lower-alkyl-Qr, cycloalkyl-Qr, lower alkoxy, lower alkenyl, cycloalkenyl-Qr, lower alkynyl, aralkyl-Qr, aryl-Qr, aryloxy, aralkoxy, a heterocyclic ring or a heterocyclyl -Qr, lower alkyl, cycloalkyl, lower alkoxy, lower alkenyl, aralkyl, aryl, aryloxy, aralkoxy and the heterocyclic ring may be substituted with at least one group selected from carboxy, amnium, nitro, cyano, -SO2NHR6 lower alkyl optionally substituted with fluoro, lower alkoxy, hydroxy i, halogen, -CONR6R7, -CHCONR6R7, -N (R7) COOR8, R7CO-, R7OCO-, R7COO-, -C (R7R9) CO2R8, -C (R7R9) CONR7R10, where R6 is hydrogen, lower alkyl or cycloalkyl or aryl; R7 and R9 are independently hydrogen or lower alkyl; R8 is hydroxy, lower alkyl, lower alkenyl, or a carboxylic acid protecting group; and R10 is hydrogen, omega-hydroxy-alkyl, phenyl, naphthyl, or heterocyclyl, with phenyl, naphthyl heterocyclyl being unsubstituted or substituted with at least one of the optionally protected hydroxy, halogen, lower alkyl, or omega-hydroxyalkyl groups.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP96117710 | 1996-11-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR010550A1 true AR010550A1 (en) | 2000-06-28 |
Family
ID=8223370
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP970105152A AR010550A1 (en) | 1996-11-06 | 1997-11-05 | CEPHALOSPORINE DERIVATIVES, THEIR USE, THE PROCESS TO MANUFACTURE THEM AND THE PHARMACEUTICAL PREPARATIONS CONTAINING THEM. |
Country Status (11)
Country | Link |
---|---|
AR (1) | AR010550A1 (en) |
BR (1) | BR9705434A (en) |
CO (1) | CO4910157A1 (en) |
HR (1) | HRP970588A2 (en) |
ID (1) | ID18086A (en) |
PE (1) | PE10799A1 (en) |
PL (1) | PL323001A1 (en) |
TR (1) | TR199701299A2 (en) |
UY (1) | UY24769A1 (en) |
YU (1) | YU43797A (en) |
ZA (1) | ZA979955B (en) |
-
1997
- 1997-11-04 ID IDP973602A patent/ID18086A/en unknown
- 1997-11-04 PE PE1997000984A patent/PE10799A1/en not_active Application Discontinuation
- 1997-11-04 UY UY24769A patent/UY24769A1/en not_active Application Discontinuation
- 1997-11-04 CO CO97064453A patent/CO4910157A1/en unknown
- 1997-11-05 PL PL97323001A patent/PL323001A1/en unknown
- 1997-11-05 ZA ZA9709955A patent/ZA979955B/en unknown
- 1997-11-05 AR ARP970105152A patent/AR010550A1/en active IP Right Grant
- 1997-11-05 TR TR97/01299A patent/TR199701299A2/en unknown
- 1997-11-05 HR HR96117710.2A patent/HRP970588A2/en not_active Application Discontinuation
- 1997-11-06 YU YU43797A patent/YU43797A/en unknown
- 1997-11-06 BR BR9705434A patent/BR9705434A/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
PE10799A1 (en) | 1999-02-10 |
BR9705434A (en) | 1999-05-11 |
ZA979955B (en) | 1998-05-06 |
TR199701299A2 (en) | 1998-05-21 |
UY24769A1 (en) | 2000-12-29 |
MX9708525A (en) | 1998-05-31 |
ID18086A (en) | 1998-02-26 |
YU43797A (en) | 1999-11-22 |
PL323001A1 (en) | 1998-05-11 |
HRP970588A2 (en) | 1998-10-31 |
CO4910157A1 (en) | 2000-04-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR023289A1 (en) | COMPOUNDS WITH INHIBITING ACTIVITY OF NEUTRAL ENDOPEPTIDASE (NEP), PHARMACEUTICAL COMPOSITION CONTAINING THEM, AND PROCEDURE FOR PREPARATION. | |
HUP0003929A2 (en) | Piperazine derivatives and their use for producing pharmaceutical compositions as anti-inflammatory agents and pharmaceutical compositions containing them | |
ES2070186T3 (en) | NEW DERIVATIVES OF 2,4-DIAMINO-PIRIMIDINA-3-OXIDO AND ITS USE IN THE PREVENTION OF HAIR LOSS. | |
DK0628311T3 (en) | Xanthine derivatives as antidepressants | |
MX9305379A (en) | NEW AMINO ACID DERIVATIVES, PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL PREPARATION CONTAINING THEM. | |
CL2003002756A1 (en) | COMPOUNDS DERIVED FROM (1-CARBAMOIL-1,1-DEFENILMETIL) -1- [SUBSTITUTED) RENT] PURROLIDINES; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND IN THE TREATMENT OF THE IRRITABLE INTESTINE SYNDROME OR INCONTINENCE. | |
ES2162676T3 (en) | PHENYLENE DERIVATIVES REPLACED IN META AND ITS USE AS ANTAGONISTS OR INHIBITORS OF INTEGRINA ALFAV, BETA3. | |
HUP9700328A2 (en) | Heteroaryl-oxazolidinones, process for their preparation, pharmaceutical compositions containing the same, their use and intermediates | |
ES2195382T3 (en) | INDOLCARBOXYL COMPOUNDS AND THEIR USE AS PHARMACEUTICAL COMPOUNDS. | |
CO4990934A1 (en) | DERIVATIVES OF TIAZOLE | |
UY25211A1 (en) | ISOQUINOLINYLGUANIDINE UROKINASE INHIBITORS | |
PT83535B (en) | METHOD FOR PREPARING PHARMACEUTICAL COMPOSITIONS CONTAINING AMINO ACID DERIVATIVES | |
ES2098023T3 (en) | GUANIDINIC STRUCTURE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | |
DE59812576D1 (en) | USE OF 1-SUBSTITUTED ISATINES FOR STAINING KERATIN-CONTAINING FIBERS | |
ATE421524T1 (en) | 5-RING HETEROCYCLES, THEIR PRODUCTION, THEIR USE AS INHIBITORS OF LEUKOCYTE ADHESION AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM | |
MX9400253A (en) | DERIVATIVES OF PIPERAZINE, PROCESS FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM. | |
DK0553016T3 (en) | New Naphthalenamides and Sulfonamides, Methods for their Preparation, and Pharmaceutical Agents Containing Them | |
ES2058572T3 (en) | NEW DERIVATIVES OF UREYLENE-2,4,6-TRIAMINE-PIRIMIDINE-3-OXIDE, ITS PREPARATION AND ITS USE IN COSMETICS AND DERMOPHARMACY. | |
AR010550A1 (en) | CEPHALOSPORINE DERIVATIVES, THEIR USE, THE PROCESS TO MANUFACTURE THEM AND THE PHARMACEUTICAL PREPARATIONS CONTAINING THEM. | |
PT873993E (en) | NEW HETEROCYCLIC COMPOUNDS PROCESS FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM | |
ATE189894T1 (en) | NAPHTHAMIDE DERIVATIVES OF 3-BETA-AMINO AZABICYCLOOCTAN OR NONANE AS ANTIPSYCHOTIC DRUGS | |
DK0466662T3 (en) | 6,7-Disubstituted-2-aminotetralins active as immunomodulators, as well as pharmaceutical preparations containing such compounds | |
AR013004A1 (en) | DERIVATIVES OF AMINOSPIROPIPERIDINE QUINAZOLINE, PHARMACEUTICAL COMPOSITION, USE OF SUCH DERIVATIVES IN THE PREPARATION OF MEDICINES, PROCESS FOR THE PREPARATION OF SUCH DERIVATIVES AND INTERMEDIATE COMPOUNDS FOR ITS EXCLUSIVE USE IN SUCH PROCESS. | |
AR005454A1 (en) | DERIVATIVES OF ISOOXACEFEM, ITS USE, PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL PREPARATIONS CONTAINING SUCH DERIVATIVES. | |
SE7508829L (en) | DIPEPTID DERIVATIVES. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant, registration |